|Articles|March 9, 2022
UBC Acquires MarketShare Movers
Acquisition will extend UBC's services to include an affordability solution.
Advertisement
UBC announced that it has acquired MarketShare Movers ("MSM"), a data-driven prescription drug benefit and affordability company. With this acquisition, UBC is extending its services to include an innovative affordability solution to patients and clients.
Read more about the acquistion
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Director of NIH Infectious Disease Institute Steps Down
5